Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Rating of “Buy” from Analysts

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) have received a consensus recommendation of “Buy” from the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have covered the stock in the last year is $20.57.

Several equities research analysts have recently commented on the stock. Needham & Company LLC lifted their price target on shares of Cellebrite DI from $17.00 to $21.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Craig Hallum upped their target price on shares of Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. TD Cowen raised their price target on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, September 23rd. Finally, JPMorgan Chase & Co. upped their price objective on Cellebrite DI from $22.00 to $24.00 and gave the company an “overweight” rating in a report on Monday.

Institutional Investors Weigh In On Cellebrite DI

A number of hedge funds have recently modified their holdings of the business. FMR LLC grew its position in shares of Cellebrite DI by 136.3% in the 3rd quarter. FMR LLC now owns 5,616,757 shares of the company’s stock valued at $94,586,000 after purchasing an additional 3,239,307 shares during the period. Meitav Investment House Ltd. lifted its stake in Cellebrite DI by 29.7% in the third quarter. Meitav Investment House Ltd. now owns 2,066,322 shares of the company’s stock valued at $34,797,000 after buying an additional 473,293 shares in the last quarter. Pembroke Management LTD boosted its holdings in shares of Cellebrite DI by 24.3% in the third quarter. Pembroke Management LTD now owns 1,908,345 shares of the company’s stock valued at $32,137,000 after buying an additional 372,619 shares during the period. Principal Financial Group Inc. bought a new stake in shares of Cellebrite DI during the third quarter worth $23,402,000. Finally, Two Sigma Advisers LP raised its holdings in shares of Cellebrite DI by 9.8% during the third quarter. Two Sigma Advisers LP now owns 1,341,100 shares of the company’s stock worth $22,584,000 after acquiring an additional 120,000 shares during the period. Institutional investors and hedge funds own 45.88% of the company’s stock.

Cellebrite DI Stock Performance

NASDAQ CLBT opened at $21.29 on Friday. The stock has a market capitalization of $4.38 billion, a P/E ratio of -13.74, a price-to-earnings-growth ratio of 2.71 and a beta of 1.51. Cellebrite DI has a 52 week low of $7.91 and a 52 week high of $21.72. The stock has a fifty day moving average of $19.14 and a 200-day moving average of $16.02.

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. The firm had revenue of $106.90 million during the quarter, compared to analyst estimates of $102.06 million. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The company’s revenue was up 27.0% on a year-over-year basis. During the same period last year, the company earned $0.09 earnings per share. Equities research analysts forecast that Cellebrite DI will post 0.32 earnings per share for the current fiscal year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.